ASHA Learning Pass

Log in and check out the Dashboard to view featured courses.

Filter Courses By
Profession
Setting
Client Age
Topic Area [clear]
Experience
Course Format
SIG
Instructional Level
Results 91 - 100 of 171
Presenter(s): William H Shapiro, AuD, CCC-A
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: This session discusses auditory brainstem implants (ABI) as an option for individuals who typically cannot benefit from conventional amplification or cochlear implants as they don't have an implantable cochlea or functioning 8th nerve. The session describes the ABI journey from candidacy to surgery to activation and follow-up. The speaker discusses the history of ABI, anatomy of the auditory pathway, interprofessional education and interprofessional practice related to ABI, and ABI clinical trial data.
Presenter(s): Michelle Leigh Arnold, AuD, CCC-A; Debra Dobbs, PhD
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: Older adults must make important decisions about their end-of-life care, and those with hearing and other communication disorders need special accommodations to participate in these important decisions to the fullest extent possible. This session discusses the communication needs of patients in the final stages of life, including the use of various hearing technologies, such as hearing aids, personal sound amplifiers, and pocket talkers. The presenters discuss tools to facilitate conversations among patients, family members, and caregivers.
Presenter(s): Dr. O’neil W. Guthrie, MS, PhD, CCC-A
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: Gene therapy offers the promise to correct inherited forms of hearing loss as well as acquired forms such as noise-induced hearing loss, ototoxicity, and presbycusis. However, there are several barriers that must be overcome before such potential can be realized. This course describes the conceptual framework that governs gene therapy today, reveals how this framework has influenced current progress, and discusses a re-imagining of inner ear gene therapy with the goal of achieving outcomes that are clinically relevant and realistic.
Presenter(s): Gayla L. Poling, PhD, CCC-A
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: Hundreds of medications commonly prescribed for anticancer treatments and some infections are known to cause auditory and/or vestibular dysfunction, known as ototoxicity. This course discusses early detection of ototoxicity through increased awareness, leveraging current tools, and clinical practice approaches for serial monitoring, all of which can provide care teams opportunities to identify adverse effects, modify treatment plans to mitigate hearing loss, and utilize individualized interventions. The speaker discusses strategies for preventing or minimizing cochlear damage to preserve quality of life for patients receiving treatment and to reduce the societal burden of hearing loss.
Webinar product cover
Presenter(s): Derek J Stiles, PhD, CCC-A
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: Congenital cytomegalovirus (cCMV) infection ranks among the leading causes of hearing loss in children. This on demand webinar will explore the characteristics of cCMV and how it affects hearing, cognition, and movement as well as strategies for clinical care, advocacy, and public health as it relates to cCMV.
Presenter(s): Kimberly M Morris, MS, CCC-SLP, BCS-S, IBCLC; Louisa N Ferrara, PhD, CCC-SLP, BCS-S, CNT, NTMCT
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: Medically complex neonates often face many challenges as they learn to feed and along the path of transitioning from tube to oral feedings. One of the most perplexing is how to progress oral feedings while the infant is still receiving positive pressure support for respiratory needs. This session explores different approaches to this challenge based on literature, clinical expertise, and multidisciplinary frameworks.
Presenter(s): Cynthia Hogan,PhD, CCC-A; Janalene Jacobson,AuD, CCC-A; Melanie Meldrum,AuD, CCC-A; Sarah Ostlie, AuD, CCC-A
Credit(s): PDHs: 1.5, ASHA CEUs*: 0.15
Summary: This course explores the most commonly fit devices for patients whose hearing is significantly poorer in one ear than the other (e.g., single-sided deafness or asymmetric hearing loss) and identify factors that impact device selection and hearing management. Using data analysis and case examples from their clinic, the speakers discuss management options for asymmetrical sensorineural hearing loss, including traditional hearing aids, Bi-CROS devices, bone conduction devices (BCD), and cochlear implants (all with or without assistive devices).This course – part of the SIGnature Series – was developed by SIG 6: Hearing and Hearing Disorders: Research and Diagnostics.
Presenter(s): Sarah Wallace, OBE, BSc, PGDip FRCSLT
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: This session discusses the vital role SLPs who work in adult ICUs play in detection and management of voice, swallowing, and airway complications following COVID-19. The speaker discusses the nature of these complications; intubation, tracheostomy, and COVID-19 features; factors to guide early treatments; and how these factors shape decision-making in post-ICU settings.
Presenter(s): Madeline Weber, MA, CCC-SLP
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: Clinical care in the intensive care unit (ICU) is exceptionally dynamic; patients may present differently day to day, or even hour by hour, and so their lab values and medication needs may fluctuate often. SLPs need to remain extraordinarily aware of changes in these lab values and medications to inform their ongoing assessment and treatment. This course examines classes of medications and lab values, their effects on a patient's presentation, and how they may influence SLP assessment and treatment as well as interprofessional decision-making.
Presenter(s): Andrea Martinez-Fisher, MS, CCC-SLP; Taite Winter, MS, CCC-SLP; Phyllis M Palmer, PhD, CCC-SLP; Shauna Murray, MS, CCC-SLP; Aaron Henry Padilla, MS, CCC-SLP, BCS-S
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: This course presents a project that investigated the effect of lower temporal resolutions on assessment of videofluoroscopic evaluation of swallowing (VFES) in adult and infant populations.
<< 6 7 8 9 10 11 12 13 14 15 >>